Lymphoma protocols (printable versions)

A -D E - OP - Z
ABVD - L.8Printable version
Alemtuzumab - L.88Printable version
BCNU Thiotepa (high dose) - B.35Printable version
BDR (Bortezomib + R) - L.53Printable version
BEACOPP-14 or BEACOPP Escalated - L.18Printable version
BEACOPDac-14 or BEACOPDac-Escalated - L.95Printable version
BEAM - L.78Printable version
BEAM Ambulatory - L.92Printable version
Bendamustine-70-R for CLL - L.44Printable version
Bendamustine-90-R for NHL - L.45Printable version
Bendamustine-90-R 1st-line CLL - L.46Printable version
Bendamustine-120 for NHL - L.47Printable version
Brentuximab vedotin - L.9Printable version
Chlorambucil - L.26Printable version
ChlVPP - L.79Printable version
CHOP-14 - L.48Printable version
CHOP-21 / R-CHOP-21 - L.80Printable version
Cladribine - L.28Printable version
Cyclophosphamide-etoposide (palliative oral) - L.39Printable version
Cytarabine (high dose) +/- R - L.54Printable version
Cytarabine (intrathecal) - L.55Printable version
Cytarabine (intraventricular) - L.56Printable version
DA-EPOCH-R (Etoposide/Inpatient) (L.66)Printable version
Depocyte - L.57Printable version
DRC - L.17Printable version
Doxorubicin for urgent use - L.58 Printable version

ESHAP / R-ESHAP - L.35Printable version
Etoposide/Dexamethasone HLH - L.89Printable version
Filgrastim - biosimilarPrintable version
Fludarabine/Cyclophosphamide R IV - L.29Printable version
Fludarabine/Cyclophosphamide R oral - L.10Printable version
GEM-P - L.36Printable version
High dose methyl-prednisolone (HDMP) - L.27Printable version
Ibrutinib - L.38Printable version
Idelalsib (Zydelig ®) + Rituximab - L.7Printable version
ICE / R-ICE - L.24Printable version
MATRix - L.33 Printable version
MaxiCHOP / Ara-C + R - L.84Printable version
Methotrexate (high dose) - generic - L.14Printable version
Methotrexate, asparaginase and dexamethasone (MeAD) - L.11Printable version
Methotrexate (high dose) for CNS prophylaxis - L.13Printable version
Methotrexate (high dose) and Cytarabine (high dose) - for primary CNS lymphoma - L.12Printable version
Methotrexate (intrathecal) - L.85Printable version
Methotrexate (weekly) - L.87Printable version
Methyl-prednisolone (high dose) - L.27Printable version
Mini-BEAM (modified) - L.30Printable version
Nivolumab - L.90Printable version
Obinutuzumab and Bendamustine - L.91Printable version
Obinutuzumab and Chlorambucil - L.22Printable version
Ofatumumab and Chlorambucil - L.21Printable version

Pentostatin - L.15Printable version
Pixantrone - L.37Printable version
PMitCEBO - L.52Printable version
R-CHOP-21 / CHOP-21 - L.80Printable version
R-CODOX-M / R-IVAC - L.49Printable version
R-BAC-500 - L.19Printable version
R-BAC-800 - L.20Printable version
R-CP - L.81Printable version
R-CVP - L.82Printable version
ESHAP / R-ESHAP (L.35)Printable version
R-GCVP - L-31Printable version
R-GDP - L-62Printable version
R-Hyper-CVAD / R-MA - L.51Printable version
R-ICE / ICE - L.24Printable version
R-MiniCHOP - L.83Printable version
R-PMitCEBO - L.52Printable version
R-VP - L.40Printable version
Rituximab (maintenance) - 1st remission - L.41Printable version
Rituximab (maintenance) - 2nd remission - L.42Printable version
Rituximab (single agent) - L.43Printable version
Rituximab SubcutaneousPrintable version
SMILE (L.67)Printable version
Temozolamide 150/200 - L.63Printable version
Topotecan / Carboplatin / Thiotepa (TopCaT) - B.48Printable version
Venetoclax - L.74Printable version
Weekly methotrexatePrintable version

Return to Lymphoma page   Return to Home page